<i>Ex Vivo</i> Profiling of PD-1 Blockade Using Organotypic Tumor SpheroidsRussell W. Jenkins, Mei-Ju Su, Chandrasekar Venkataramani et al.|Cancer Discovery|2017Cited by 591
Antitumor activity of the WEE1 inhibitor AZD1775 as a monotherapy and in combination with the PARP inhibitor olaparib in patient-derived explant (PDX) modelsM.J. O’Connor, J.F. Liu, Rajesh Odedra et al.|European Journal of Cancer|2016Cited by 3
Supp. Movie 1 from <i>Ex Vivo</i> Profiling of PD-1 Blockade Using Organotypic Tumor SpheroidsRussell W. Jenkins, Mei-Ju Su, Amir Reza Aref et al.|Unknown|2023Cited by 0
Supp. Movie 3 from <i>Ex Vivo</i> Profiling of PD-1 Blockade Using Organotypic Tumor SpheroidsRussell W. Jenkins, Mei-Ju Su, Amir Reza Aref et al.|Unknown|2023Cited by 0
Table S4 from <i>Ex Vivo</i> Profiling of PD-1 Blockade Using Organotypic Tumor SpheroidsRussell W. Jenkins, Mei-Ju Su, Amir Reza Aref et al.|Unknown|2023Cited by 0